Defendant

Synthon Pharmaceuticals, Inc.

2 cases as defendant.

Cases
2
Active
0
2 closed
Filed
2018–2019
Top venue
M.D. North Carolina
1 case

Celgene Corporation v. Synthon Pharmaceuticals, Inc. et al.

dismissed/consolidated
Docket:
2:19-cv-09737
Filed:
2019-04-12
Terminated:
2019-05-13
Patents:100936471009364810093649
π Celgene CorporationΔ Synthon Pharmaceuticals, Inc.Δ Alvogen

Celgene filed this D.N.J. action against Synthon (Alvogen) on the '262, '939, '428, '427 and the '647/'648/'649 patents. The docket shows termination on May 13, 2019, indicating dismissal or consolidation.

Celgene Corporation v. Synthon Pharmaceuticals, Inc.

dismissed
Docket:
1:18-cv-00540
Filed:
2018-06-21
Terminated:
2018-07-25
Patents:8198262867393987354288828427
π Celgene CorporationΔ Synthon Pharmaceuticals, Inc.

Celgene filed a § 271 patent infringement action against Synthon in M.D.N.C. asserting US 8,198,262, 8,673,939, 8,735,428, and 8,828,427. The case was terminated July 25, 2018 by a stipulation of dismissal, described as a parallel/companion filing to the New Jersey action.